Catherine Wood's APGE Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 3.25 M shares of Apogee Therapeutics, Inc. (APGE) worth $9.85 M, representing 0.07% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Catherine Wood has initiated a new position in APGE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Apogee Therapeutics (APGE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Apogee Therapeutics (APGE) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +3.25 M | New Buy | 3.25 M | $3.03 |
Catherine Wood's Apogee Therapeutics Investment FAQs
Catherine Wood first purchased Apogee Therapeutics, Inc. (APGE) in Q4 2025, acquiring 3,252,033 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Apogee Therapeutics, Inc. (APGE) for 1 quarters since Q4 2025.
Catherine Wood's largest addition to Apogee Therapeutics, Inc. (APGE) was in Q4 2025, adding 3,252,033 shares worth $9.85 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 3,252,033 shares of Apogee Therapeutics, Inc. (APGE), valued at approximately $9.85 M.
As of the Q4 2025 filing, Apogee Therapeutics, Inc. (APGE) represents approximately 0.07% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Apogee Therapeutics, Inc. (APGE) was 3,252,033 shares, as reported at the end of Q4 2025.